Fibrinogen-like protein 2 promotes tumor immune suppression by regulating cholesterol metabolism in myeloid-derived suppressor cells
Lei Wu, Xudong Liu, Juan Lei, Nan Zhang, Huakan Zhao, Jiangang Zhang, Huan Deng, Yongsheng Li · 2023
Read Fibrinogen-like protein 2 promotes tumor immune suppression by regulating cholesterol metabolism in myeloid-derived suppressor cells by Lei Wu, Xudong Liu, Juan Lei, Nan Zhang, Huakan Zhao, Jiangang Zhang, Huan Deng, Yongsheng Li (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10711877.txt.
Description
Lei Wu and co-authors uncover a protein that helps tumors hide from the immune system in a 2023 study. The protein, fibrinogen-like protein 2, acts on myeloid-derived suppressor cells, immune cells that tumors recruit to blunt attack. Taming those cells is a known route to stronger immunotherapy.
In mouse tumor models, removing the protein boosted killer T cell responses and cut the build-up of one suppressor cell type. The protein works by steering cholesterol handling inside the suppressor cells. That shift raises reactive oxygen output and fires a stress signal, which locks in their suppressive state. Blocking the protein or its cholesterol pathway freed the cells to mature instead. Pairing such a block with a standard checkpoint drug, the authors suggest, could sharpen cancer treatment.
Catalog record
| CREATOR | Lei Wu, Xudong Liu, Juan Lei, Nan Zhang, Huakan Zhao, Jiangang Zhang, Huan Deng, Yongsheng Li |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |